Background illustration for clinical trials search

Paid Clinical Trials San Francisco

Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss

for
Sensorineural Hearing Loss, Bilateral
Location: San Francisco CA, Iowa City IA, Nashville TN
Sponsor: Eli Lilly and Company

Sex: All

Age: 0+

Code: NCT05821959

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for
Persistent Corneal Epithelial Defect
Location: Petaluma CA, Torrance CA, Grand Junction CO,
Sponsor: Glaukos Corporation

Sex: All

Age: 2+

Code: NCT05966493

Phase 2, Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes

for
Congenital Heart Disease, Aortic Valve Stenosis,
Location: San Francisco CA, Columbus OH, Toronto
Sponsor: Queen Silvia Children's Hospital, Gothenburg, Sweden

Sex: All

Age: 0

Code: NCT05386173

Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Fremont CA, Stockton CA, Woodland CA, Elk Grove CA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase 3, Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: San Francisco CA, Oakland CA, Madera CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: San Francisco CA, Palo Alto CA, Woodland CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Martinez CA, Mission Hills CA, South Pasadena CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase 3, Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for
Renal Cell Carcinoma
Location: San Francisco CA, Nashville TN, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07049926

Phase 1, Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: San Francisco CA, Oakland CA, Palo Alto CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: San Francisco CA, Vallejo CA, Sacramento CA,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

Skin Flap Visible Light Spectroscopy (VLS) Oximetry for Monitoring Free-Flap Ischemia During Breast Reconstruction and Recovery

for
Ischemia
Location: Burlingame CA
Sponsor: Spectros Corporation

Sex: All

Age: 0+

Code: NCT01173133

Recruiting

Evaluation of the Optimal Transition Program

for
ESRD, Hemodialysis
Location: Oakland CA, Sacramento CA, Memphis TN
Sponsor: Satellite Healthcare

Sex: All

Age: 18+

Code: NCT04263233

Recruiting

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Oakland CA, Phoenix AZ, Vancouver, Aurora CO, Calgary,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT05995353

Phase 3, Recruiting

An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

for
Methylmalonic Acidemia
Location: Palo Alto CA, Los Angeles CA, San Diego CA, Edmonton,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 1+

Code: NCT05295433

Phase 1, Phase 2, Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

for
Buccal Mucosa Squamous Cell Carcinoma,
Location: San Francisco CA, Palo Alto CA, San Jose CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04333537

Phase 2, Phase 3, Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

for
Castration-Resistant Prostatic Cancer, Metastasis
Location: San Francisco CA, Los Angeles CA, Orange CA, Seattle WA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06863272

Phase 1, Phase 2, Recruiting

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

for
Diabetic Foot Ulcer
Location: San Francisco CA, Fresno CA, Sylmar CA, Los Angeles CA,
Sponsor: Origin Inc.

Sex: All

Age: 22 - 70+

Code: NCT03078933

Recruiting